Synthesis of Novel tricyclic pyrazolo(1,4)oxathiinopyrazines and Evaluation of Their Competency Towards the Inhibition of Lactate Dehydrogenase Activity-Inhibition of LDH Activity

Abstract

We have evaluated the LDH inhibitory property of novel pyrazolo[4′,3′:5,6][1,4]oxathiino[2,3-b]pyrazine derivatives which have been synthesized from easily available starting materials through a one-pot protocol that offers the use of elemental sulfur as the sulfur source. These newly synthesized compounds may aid to drug development for neoplastic and non-neoplastic diseases characterized by increased glucose metabolism. Additionally, they may act as suitable starting materials which can be further structurally modified for the development of new LDH inhibitors with higher efficacy and specificity.

Key words

pyrazolo[4′,3′:5,6][1,4]oxathiino[2,3-b]pyrazines - LDH inhibition - Elemental sulfur - One-pot protocol

• References

• 1 Viglianisi C, Menichett S. Dihydrobenzo[1,4]oxathiine: a multi-potent pharmacophoric heterocyclic nucleus. Current Medicinal Chemistry 2010; 17: 915-928
• 2 Foks H, Trapkowska I, Janowiec M. et al. studies on pyrazine derivatives. 38. synthesis, reactions, and tuberculostatic activity of pyrazinyl-substituted derivatives of hydrazinocarbodithioic acid. Chemistry of Heterocyclic Compounds 2004; 40: 1185-1193
• 3 Field JB, Dolendo EC, Mireles A. et al. Evaluation of the effect of a pyrazolone derivative KB-95 on the toxicity and activity of some anticancer drugs. Cancer Research 1966; 26: 1371-1375
• 4 Toth B. Tumorigenesis studies with 1,2-dimethylhydrazine dihydrochloride, hydrazine sulfate, and isonicotinic acid in golden hamsters. Cancer Research 1972; 32: 804-807
• 5 Nagashima S. Effect of thiocyanate on the pyridine-pyrazolone method for the spectrophotometric determination of cyanide. Analytical Chemistry 1983; 55: 2086- 2089
• 6 Fryer RI, Zhang P, Rios R. et al. Structure-activity relationship studies at benzodiazepine receptor (BZR): a comparison of the substituent effects of pyrazoloquinolinone analogs. Journal of Medicinal Chemistry 1993; 36: 1669-1673
• 7 Ebner S, Wallfisch B, Andraos J. et al. N-Aminopyrroledione–hydrazonoketene–pyrazolium oxide–pyrazolone rearrangements and pyrazolone tautomerism. Organic and Biomolecular Chemistry 2003; 1: 2550-2555
• 8 Ferlin MG, Chiarelotto G, Acqua SD. et al. Novel anellated pyrazoloquinolin-3-ones: synthesis and in vitro BZR activity. Bioorganic and Medicinal Chemistry 2005; 13: 3531-3541
• 9 Chande MS, Barve PA, Suryanarayan V. Synthesis and antimicrobial activity of novel spirocompounds with pyrazolone and pyrazolthione moiety. Journal of Heterocyclic Chemistry 2007; 44: 49-53
• 10 Kimata A, Nakagawa H, Ohyama R. et al. New series of antiprion compounds: pyrazolone derivatives have the potent activity of inhibiting protease-resistant prion protein accumulation. Journal of Medicinal Chemistry 2007; 50: 5053-5056
• 11 Caruso F, Pettinari C, Marchetti F. et al. Synthesis, molecular structure (X-ray and DFT), and solution behavior of titanium 4-Acyl-5-pyrazolonates. Correlations with related antitumor beta-diketonato derivatives. Inorganic Chemistry 2007; 46: 7553-7560
• 12 Ma R, Zhu J, Liu J. et al. Microwave-assisted one-pot synthesis of pyrazolone derivatives under solvent-free conditions. Molecules 2010; 15: 3593-3601
• 13 Mariappan G, Saha BP, Bhuyan NR. et al. Evaluation of antioxidant potential of pyrazolone derivatives. Journal of Advanced Pharmaceutical Technology and Research 2010; 1: 260-267
• 14 Kobayashi K, Konishi N, Suzuki T. et al. One-Pot Synthesis of 1,4-Oxathiino[2,3-b]quinoxalines or -pyrazines from 2,3-Dichloroquinoxaline or -pyrazine and 1-Aryl-2-bromoalkan-1-ones. Helvetica Chimica Acta 2013; 96: 1452-1456
• 15 Mosti L, Menozzi G, Schenone P. Reaction of sulfene with heterocyclic N,N-disubstituted α-aminomethyleneketones. VII. Synthesis of 1,2-oxathiino-[5,6-g]benzothiazole derivatives. Journal of Heterocyclic Chemistry. 1981; 18: 1069-1071
• 16 El-Kashef H, El-Emary TI, Gasquet M. et al. Pharmazie, New pyrazolo[3,4-b]pyrazines: synthesis and biological activity. 2000; 55: 572-576
• 17 Mukherjee P, Das AR. One-flask synthesis of pyrazolone thioethers involving catalyzed and uncatalyzed thioetherification pathways of pyrazolones. Organic and Biomolecular Chemistry 2017; 15: 7267-7271
• 18 Kausar N, Das AR. CuI–Zn(OAc)₂ catalyzed C(sp²)–H activation for the synthesis of pyridocoumarins through an uncommon Cu^I–Cu^III switching mechanism: A fast, solvent-free, combo-catalytic, ball milling approach. Tetrahedron Letters 2017; 58: 2602-2607
• 19 Paul S, Pradhan K, Ghosh S. et al. Magnetically retrievable nano crystalline nickel ferrite-catalyzed aerobic, ligand-free c-n, c-o and c-c cross- coupling reactions for the synthesis of a diversified library of heterocyclic molecules. Advanced Synthesis and Catalysis 2014; 356: 1301-1316
• 20 Di Stefano G, Manerba M, Di Ianni L. et al. Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment. Future Medicinal Chemistry 2016; 8: 713-725
• 21 Valvona CJ, Fillmore HL, Nunn PB. et al. The regulation and function of lactate dehydrogenase A: Therapeutic potential in brain tumor. Brain Pathology 2016; 26: 3-17
• 22 Romero-Garcia S, Moreno-Altamirano MM, Prado-Garcia H. et al. Lactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Frontiers in Immunology 2016; 7: 52
• 23 Fauber BP, Dragovich PS, Chen J. et al. Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase. Bioorganic and Medicinal Chemistry Letters 2013; 23: 5533-5539
• 24 Cameron A, Read J, Tranter R. et al. Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity. Journal of Biological Chemistry 2004; 279: 31429-31439
• 25 Granchi C, Capecchi A, Del Frate G. et al. Development and validation of a docking-based virtual screening platform for the identification of new lactate dehydrogenase inhibitors. Molecules 2015; 20: 8772-8790
• 26 Rani R, Kumar V. Recent update on human lactate dehydrogenase enzyme 5 (hLDH5) inhibitors: A promising approach for cancer chemotherapy. Journal of Medicinal Chemistry 2016; 59: 487-496